(202 days)
No
The summary describes a standard vital signs monitor using established technologies and does not mention any AI or ML components. The performance studies focus on traditional accuracy metrics for blood pressure, pulse oximetry, and temperature.
No
The device is intended to monitor vital signs, not to treat a condition or restore a function.
Yes
The device is intended to monitor a patient's vital signs, which involves collecting data (blood pressure, pulse rate, oxygen saturation, temperature) to assess their physiological state. While it doesn't provide a diagnosis itself, the data it collects is crucial for healthcare professionals in making diagnostic decisions about a patient's condition.
No
The device description explicitly states it is a "portable device" that includes an "integrated printer" and is capable of operation from an "external AC mains power source or an internal lead-acid rechargeable battery." These are all hardware components, indicating it is not a software-only device.
Based on the provided text, the DINAMAP® Pro Series 100, 200, 300, 400 Monitor is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use clearly states that the device is for monitoring a patient's vital signs (blood pressure, pulse rate, oxygen saturation, temperature) at the bedside or during transport. This involves direct interaction with the patient's body (e.g., blood pressure cuff, pulse oximeter sensor, temperature probe).
- IVD Definition: In Vitro Diagnostics (IVDs) are devices used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening. The DINAMAP Pro Series does not analyze specimens in vitro (outside the body).
- Device Description: The description details the parameters measured and how they are obtained (non-invasive blood pressure, pulse oximetry, oral/rectal temperature), all of which are direct measurements from the patient.
Therefore, the DINAMAP Pro Series is a patient monitoring device, not an IVD.
N/A
Intended Use / Indications for Use
The DINAMAP® Pro Series 100, 200, 300, 400 Monitor is intended to monitor a single adult, pediatric or neonatal patient's vital signs at the bedside or during intra-hospital or ground transport. Vital signs parameters include non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate and/or oxygen saturation (pulse oximetry). The portable device is designed for use in numerous clinical settings in various hospital departments such as emergency, radiology, recovery, medical/surgical, labor and delivery, endoscopy, cardiac step-down. It can also be used in satellite areas, physicians' offices, or alternate care settings.
Product codes
DXN, DSK, DSJ, DQA, DPZ, FLL, DSF
Device Description
The DINAMAP Pro Monitor, Series 100, 200, 300, 400 is a prescription device intended for use only by health care professionals. Four configurations of the monitor - all with an integrated printer - will offer the following vital signs parameters:
- DINAMAP Pro Series 100: Non-Invasive Blood Pressure and Pulse Rate
- DINAMAP Pro Series 200: Non-Invasive Blood Pressure and Monitor/Predictive Oral/Rectal Temperature
- DINAMAP Pro Series 300: Non-Invasive Blood Pressure and Nellcor® Pulse Oximetry and Pulse Rate
- DINAMAP Pro Series 400: Non-Invasive Blood Pressure and Pulse Rate; Monitor/Predictive Oral/Rectal Temperature; and Nellcor® Oxygen Saturation and Pulse Rate (Pulse Oximetry)
This portable device includes an integrated printer and is capable of operation from an external AC mains power source or an internal lead-acid rechargeable battery. The device uses the same technology and materials as the predicate devices, the DINAMAP MPS™ Select™ Multiparameter System (K955113 cleared 8/15/96); the DINAMAP MPS™ Select™ Portable Monitor (K971569 cleared 9/19/97); and the DINAMAP® Compact Monitor (K970182 cleared 8/18/97).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult, pediatric or neonatal
Intended User / Care Setting
Health care professionals. At the bedside or during intra-hospital or ground transport. In numerous clinical settings in various hospital departments such as emergency, radiology, recovery, medical/surgical, labor and delivery, endoscopy, cardiac step-down. It can also be used in satellite areas, physicians' offices, or alternate care settings.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Clinical Study for Accuracy - Overall System Efficacy (NIBP):
Accuracy established in adult, pediatric, and neonatal populations with ANSI/AAMI SP10 clinical study for the DINAMAP MPS Select NIBP Module. The NIBP parameter of the new monitor has the same NIBP algorithm as the predicate devices.
Bench Testing, ANSI/AAMI SP10 (NIBP):
New device subjected to and passed requirements for Stability, Safety Requirements (Maximum Cuff Pressure, Cuff Deflation, Electrical Safety, Conductive Components), and Performance Requirements (Pressure Indicator Accuracy, Battery-Powered Devices).
Oxygen Saturation (SpO2) Clinical Studies:
Two clinical studies.
- Co-Oximeter Correlation Study: Compared oxygen saturation measurements from three new devices with arterial blood oxygen saturation co-oximeter measurements from three healthy subjects. Breathedown in five plateaus from 100% to 70%. Pooled results met sensor specifications.
- Non-Invasive Controlled Hypoxia Study: Compared oxygen saturation measurements from three new devices with arterial blood oxygen saturation pulse oximeter measurements from 35 subjects across the full Nellcor sensor line. Met oxygen saturation with all Nellor sensors.
Oxygen Saturation (SpO2) Bench Testing:
Three bench tests performed: Saturation Comparison Verification Study, Low Perfusion/Low Signal Saturation Study, Pulse Rate Comparison Study. New devices met acceptance criteria.
Temperature Bench Testing:
To establish monitor mode or probe accuracy, liquid-bath testing according to ASTM E 1112 86 (Reapproved 1991).
To establish predictive mode accuracy, liquid-bath testing against Alaris Medical Systems IVAC® 2080 Measurement according to a Critikon-developed procedure.
Confirmed ability of two new devices to accurately read resistance before and after liquid-bath testing. Four probes tested with two new devices over operational temperature range in monitor and predictive modes. Results demonstrated ability to determine monitor mode temperatures relative to mercury-in-glass thermometer and predictive mode temperatures relative to IVAC 2080 Measurement System within specified error ranges.
Temperature Clinical Studies:
Temperature data collected orally from 78 adult and pediatric subjects. Test device temperature compared to a reference mercury-in-glass thermometer reading collected over a three-minute period. Mean difference of 0.13ºF, S.D. of 0.31, within acceptance criteria of 2.0ºF for a clinically significant difference > 1.0 F.
Key Metrics
For Temperature Clinical Studies:
Mean difference of 0.13ºF, S.D. of 0.31 - well within acceptance criteria of 2.0ºF.
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
FEB 2 4 2000
Image /page/0/Picture/1 description: The image shows the word "CRITIKON" in all caps. The "I" in "CRITIKON" is replaced with a heartbeat line. Underneath the word "CRITIKON" is the phrase "VITAL ANSWERS" in a smaller font with a trademark symbol.
510(k) Summary
August 3, 1999
Device Identification
Dinamap® Pro Monitor, Series 100, 200, 300, 400
Submitted by
Critikon Company, L.L.C., 4110 George Road, Tampa, Florida 33634
Contact Person
Tom English, Director, Regulatory Affairs and Clinical Services, Critikon Company LLC, Tampa, FL
Common Name
Physiological or Vital Signs Monitor, Patient Monitor includes:
- Non-Invasive Blood Pressure and Pulse Rate .
- Pulse Oximetry and Pulse Rate .
- Temperature, Predictive and Monitor Mode .
| Classification Name | Product Code | 21 CFR |
|---|---|---|
| System, Measurement, Blood Pressure, Noninvasive | DXN | 870.1130 |
| Computer, Blood Pressure | DSK | 870.1110 |
| Alarm, Blood Pressure | DSJ | 870.1100 |
| Oximeter | DQA | 870.2700 |
| Oximeter, Ear | DPZ | 870.2710 |
| Thermometer, Clinical Electronic | FLL | 880.2910 |
| Recorder, Paper Chart | DSF | 870.2810 |
Indications for use
The DINAMAP® Pro Series 100, 200, 300, 400 Monitor is intended to monitor a single adult, pediatric or neonatal patient's vital signs at the bedside or during intra-hospital or ground transport. Vital signs parameters include non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate and/or oxygen saturation (pulse oximetry). The portable device is designed for use in numerous clinical settings in various hospital departments such as emergency, radiology, recovery, medical/surgical, labor and delivery, endoscopy, cardiac step-down. It can also be used in satellite areas, physicians' offices, or alternate care settings.
Device Description
The DINAMAP Pro Monitor, Series 100, 200, 300, 400 is a prescription device intended for use only by health care professionals. Four configurations of the monitor - all with an integrated printer - will offer the following vital signs parameters:
- . DINAMAP Pro Series 100: Non-Invasive Blood Pressure and Pulse Rate
- DINAMAP Pro Series 200: Non-Invasive Blood Pressure and Monitor/Predictive Oral/Rectal . Temperature
- . DINAMAP Pro Series 300: Non-Invasive Blood Pressure and Nellcor® Pulse Oximetry and Pulse Rate
- . DINAMAP Pro Series 400: Non-Invasive Blood Pressure and Pulse Rate; Monitor/Predictive Oral/Rectal Temperature; and Nellcor® Oxygen Saturation and Pulse Rate (Pulse Oximetry)
This portable device includes an integrated printer and is capable of operation from an external AC mains power source or an internal lead-acid rechargeable battery. The device uses the same technology and materials as the predicate devices, the DINAMAP MPS™ Select™ Multiparameter System (K955113 cleared 8/15/96); the DINAMAP MPS™ Select™ Portable Monitor (K971569 cleared 9/19/97); and the DINAMAP® Compact Monitor (K970182 cleared 8/18/97).
1
Image /page/1/Picture/0 description: The image shows the word "CRITIKON" in all caps. Underneath the word is a line that extends from under the "C" to under the "T", where it turns into a heart rate line. Underneath the heart rate line is the phrase "VITAL ANSWERS" with a trademark symbol.
Clinical and Bench Testing
Non-Invasive Blood Pressure (NIBP)
For NIBP performance, Critikon used ANSI/AAMI SP10-1992: "Electronic or automated sphygmomanometers" and ANSI/AAMI SP10A-1996: Amendment to ANSI/AAMI SP10-1992: American National Standard for Electronic or Automated Sphygmomanometers.
The following requirements of ANSI/AAMI SP10 and SP10A were met:
- . Labeling (4.1)
- Stability (4.2.4, environmental requirements, 4.2.1, 4.2.2, and 4.2.3 were not included) .
- . Safety (4.3)
- . Performance (4.4)
To evaluate environmental performance, Critikon met the requirements contained in the November 1993 Draft Reviewer Guidance for Premarket Notification Submissions of the Anesthesiology and Respiratory Devices Branch of the Division of Cardiovascular, Respiratory, and Neurological Devices.
Clinical Study for Accuracy - Overall System Efficacy:
Accuracy of the NIBP algorithm was established in the adult, pediatric, and neonatal populations with the ANSI/AAMI SP10 clinical study for the DINAMAP MPS Select NIBP Module used in the DINAMAP MPS Select Multiparameter System and the DINAMAP MPS Select Portable Monitor (K955113 cleared 8/15/96).
The NIBP parameter of the new monitor has the same NIBP algorithm that calculates blood pressure from measured oscillations as the DINAMAP MPS™ Select™ Multiparameter System (K955) 13 cleared 815/96); the DINAMAP MPS™ Select™ Portable Monitor (K971569 cleared 9/19/97); and the DINAMAP® Compact Monitor (K970182 cleared 8/18/97),
Moreover, the NIBP parameter of the new monitor has the same intended use and labeling claims as the DINAMAP MPS Select NIBP Module; the same software runs in the same processor family under the same operating system as the predicate device; and the same accessories - air hoses and blood pressure cuffs.
Bench Testing, ANSI/AAMI SP10
With the exception of the environmental performance, the new device was subjected to the remainder of ANSI/AAMI SP 10 bench testing requirements, including:
- . Stability: 4.2.4.1 Voltage Range; and 4.2.4.2 Life
- . Safety Requirements: 4.3.1.1 Maximum Cuff Pressure; 4.3.1.2. Cuff Deflation; 4.3.2 Electrical Safety; and 4.3.3 Conductive Components
- . Performance Requirements: 4.4.1 Pressure Indicator Accuracy; and 4.4.3 Battery-Powered Devices.
The new device passed all tests.
2
Image /page/2/Picture/0 description: The image shows the word "CRITIKON" in large, bold, black letters. Underneath the word is a line that resembles an EKG, and the words "VITAL ANSWERS" are written in a smaller font. The letters are all capitalized and the word "ANSWERS" has a trademark symbol next to it.
Oxygen Saturation (SpO2)
Nellcor Puritan Bennett, Inc. (NPB) conducted studies (two clinical and three bench) to demonstrate the accuracy of the pulse oximetry parameter to the new device with Nellcor FE101 hardware, BE3050 software and the Nellcor sensor line.
Clinical Studies
Two clinical studies were performed to evaluate the accuracy of the new device's derived oxygen.
- Co-Oximeter Correlation Study -- compared oxygen saturation measurements obtained with three new devices with . arterial blood oxygen saturation co-oximeter measurements obtained from three healthy subjects. Breathedown progressed in five plateaus from 100% to 70% in increments of approximately 5%. After data collection at the lowest plateau was complete, the subjects were rapidly re-saturated to 100%. Pooled results for all three subjects indicated that the three new devices met sensor specifications.
- . Non-Invasive Controlled Hypoxia Study - compared oxygen saturation measurements obtained with three new devices with arterial blood oxygen saturation pulse oximeter measurements obtained from 35 subjects across the full Nellcor sensor line.
The oxygen saturation parameter of the new devices met oxygen saturation with all Nellor sensors.
Bench Testing
The following three bench tests were performed:
- . Saturation Comparison Verification Study
- Low Perfusion/Low Signal Saturation Study .
- . Pulse Rate Comparison Study
In all cases the new devices met the acceptance criteria
Temperature
Temperature tests performed were:
- To establish monitor mode or probe accuracy, liquid-bath testing according to ASTM E 1112 86 (Reapproved 1991); . Standard Specification for Electronic Thermittent Determination of Patient Temperature was followed.
- . To establish predictive mode accuracy; liquid-bath testing was conducted to establish equivalence between the new device and the Alaris Medical Systems IVAC® 2080 Measurement according to a Critikon-developed procedure.
Bench Testing
To determine clinical accuracy, Critikon conducted an in-house study comparing temperatures obtained from 78 subjects using the new device and a mercury-in-glass thermometer. The ability of two new devices to accurately read resistance was confirmed before and after liquid-bath testing. Four probes were then tested with the two new devices over the operational temperature range - both in monitor and predictive modes. Test results demonstrated the ability of the new device to determine monitor mode temperatures relative to a mercury-in-glass thermometer and predictive mode temperatures relative to an IVAC 2080 Measurement System within the maximum error ranges specified in Table 1 of ASTM E 1112 - 86 (Reapproved 1991).
Clinical Studies
Temperature data was collected orally from 78 adult and pediative temperature was obtained from the test device and compared to a reference mercury-in-glass thermometer temperature reading collected over a three-minute period. A clinically significant difference was defined as a mean difference > 1.0 F. Data analysis showed a mean difference of 0.13ºF, with a S.D. of 0.31 - well within acceptance criteria of 2.0ºF.
3
Image /page/3/Picture/1 description: The image is a circular seal for the Department of Health & Human Services - USA. The seal features the department's name in a circular arrangement around the edge. In the center of the seal is a stylized image of an eagle or bird-like figure, composed of three thick, curved lines that suggest wings or feathers. The overall design is simple and monochromatic, with a focus on the department's name and the symbolic bird emblem.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 2 4 2000
Mr. Thomas English Critikon Company, L.L.C. 4502 Woodland Corporate Boulevard 33614 Tampa, FL
Re: K992638 Dinamap® Pro Series Monitor, Models 100, 200, 300, 400 Monitor Regulatory Class: II (two) Product Code: MW I Dated: November 23, 1999 November 26, 1999 Received:
Dear Mr. English:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
Page 2 - Mr. Thomas English
This letter will allow you to beqin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Material test results
Celia M. Witten, Ph.D., M.D. Acting Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
INDICATIONS FOR USE
510(k) Number (if known):
Device Name: DINAMAP® Pro Series 100, 200, 300, 400 Monitor
Indications for Use:
The DINAMAP® Pro Series 100, 200, 300, 400 Monitor is intended to monitor a single adult, pediatric or neonatal patient's vital signs parameters include noninvasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate and/or temperature and/or oxygen saturation (pulse oximetry). The portable device is designed for use in numerous clinical settings in various hospital departments such as emergency, radiology, recovery, medical/surgical, labor and delivery, endoscopy, cardiac step-down. It can also be used in satellite areas, physicians' offices, or alternate care settings.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Concurrence of CDRH, Office of Device Evaluation (ODE)
Rita B. Campbell
(Division Sign-Off)
Division of Cardiovascular, Respiratory,
and Neurological Devices
510(k) Number K992636
Prescription Use (per 21 CFR 801.109
OR
Over-The Counter Use (Optional Format 1-2-96)